The Temperature Sensitive Patch segmentation by application delineates distinct therapeutic and consumer use‑cases that collectively define market size. Pain‑management patches, which deliver analgesics such as NSAIDs or lidocaine in response to skin temperature fluctuations, represent the largest share, driven by chronic musculoskeletal conditions and post‑operative care; they account for roughly 38% of total revenue. Hormone‑therapy patches, primarily for transdermal estrogen or testosterone delivery, occupy about 22%, reflecting growing acceptance in endocrine disorder treatment and gender‑affirming therapy. Dermatology applications—including acne, psoriasis, and wound‑healing patches—contribute 18%, supported by rising prevalence of skin disorders and demand for localized, temperature‑controlled drug release. Veterinary patches, used for large‑animal pain and infection control, hold a 12% share, benefiting from expanding livestock health management programs. Finally, sports‑medicine patches, targeting athletes for performance recovery and inflammation control, make up the remaining 10%, propelled by heightened focus on rapid rehabilitation and non‑oral dosing options.